☆ 4.2 Article

Efficacy and Safety of CPX-351 Versus 7+3 in a Phase 3 Exploratory Analysis in Patients with High-Risk/Secondary Acute Myeloid Leukemia (sAML) with Prior Hypomethylating Agent (HMA) Exposure Who Achieved Remission

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)

Get Full Text
Add to Collection

Journal

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
Volume 26, Issue 3, Pages S102

Publisher

Elsevier BV
DOI: 10.1016/j.bbmt.2019.12.605

Keywords

-

Categories

-

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.2
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available
Webinars Posters Questions Hubs Funding Journals Papers Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.